Stephen V Liu, MD

@StephenVLiu

Thoracic Oncologist, Chief of Heme/Onc @Georgetown University; Head of Developmental Therapeutics @LombardiCancer; Co-Chair #DCLung25 & #TexasLung26; #HereWeGo

Georgetown, Washington, DC

Joined September 2011

3KFollowing

28KFollowers

Pinned

Stephen V Liu, MD@StephenVLiu · Jun 30

#DCLung25 is a 1-day, @IASLC endorsed comprehensive lung cancer conference, Saturday, Oct 4th, Washington DC. A great time to visit our nation's capital & learn from the top lung cancer experts in the world! CME, MOC, nursing, pharmacy credits offered! medstarhealth.org/dclung25

StephenVLiu's tweet image. #DCLung25 is a 1-day, @IASLC endorsed comprehensive lung cancer conference, Saturday, Oct 4th, Washington DC.

A great time to visit our nation's capital &amp; learn from the top lung cancer experts in the world! CME, MOC, nursing, pharmacy credits offered!

medstarhealth.org/dclung25

7.0K

Stephen V Liu, MD Retweeted

ESMO - Eur. Oncology@myESMO · 10 h

Stay ahead with the #ESMOVirtualJournalClub – July 2025! We’re diving into new studies on #NSCLC and #GEJ cancers. Register now: 🔗 ow.ly/7Gty50WsGcz

1.0K

Stephen V Liu, MD@StephenVLiu · 11 h

Be sure to attend #DCLung25 - Saturday, October 4th in Washington DC: a one-day @IASLC endorsed lung cancer conference with experts like Dr. Mark Kris from @MSKCancerCenter, who will weigh in on targeted therapy management in lung cancer. Register today! medstarhealth.org/dclung25

StephenVLiu's tweet image. Be sure to attend #DCLung25 - Saturday, October 4th in Washington DC: a one-day @IASLC endorsed lung cancer conference with experts like Dr. Mark Kris from @MSKCancerCenter, who will weigh in on targeted therapy management in lung cancer. Register today!

medstarhealth.org/dclung25

584

Stephen V Liu, MD@StephenVLiu · Jul 23

#ALK is a viable target even in squamous NSCLC, demonstrated by this case + review in @ClinicalLung. However, significant variability in quality of response. While most respond, many brief courses of crizotinib, one on 1L alectinib for 5y and counting. clinical-lung-cancer.com/article/S1525-…

StephenVLiu's tweet card. DNA-based next-generation sequencing (NGS) has identified ALK rearrangements in lung squamous cell carcinoma (LUSC), a subset of non-small cell lung cancer traditionally lacking effective targeted...

3.0K

Stephen V Liu, MD@StephenVLiu · Jul 22

NEOIPOWER results @LungCaJournal: neoadjuvant icotinib (8 wks) + chemotherapy (2 cycles) in resectable stage II-IIIB #EGFR NSCLC. Single arm phase II study showed RR 83.3% with DCR 96.7% but MPR rate only 6.7% with no pCR. lungcancerjournal.info/article/S0169-…

StephenVLiu's tweet card. Most surgically resected patients with non-small cell lung cancer (NSCLC) inevitably develop local recurrence or distant metastasis, leading to poor prognosis [1,2]. Compared with surgery alone,...

1.0K

Stephen V Liu, MD@StephenVLiu · Jul 22

Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Cristina Merkhofer joins to discuss best practice for advanced squamous NSCLC. Register today! Trainees attend free! medstarhealth.org/dclung25

StephenVLiu's tweet image. Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference!

Dr. Cristina Merkhofer joins to discuss best practice for advanced squamous NSCLC. Register today! Trainees attend free!

medstarhealth.org/dclung25

946

Stephen V Liu, MD Retweeted

IASLC@IASLC · Jul 19

Committee Spotlight: Dr. Tom E. Stinchcombe outlines the IASLC Multidisciplinary Clinical Science Committee's global initiatives and research goals. 🔗 Learn more: bit.ly/4m63DlC #LCSM

1.0K

Stephen V Liu, MD@StephenVLiu · Jul 21

Join us at #DCLung25 on Saturday, October 4th in downtown Washington, DC for the latest updates in lung cancer. Dr. Christine Lovly @christine_lovly joins the faculty to discuss biomarkers for NSCLC. @IASLC endorsed & CME / MOC credits - register today! medstarhealth.org/dclung25

StephenVLiu's tweet image. Join us at #DCLung25 on Saturday, October 4th in downtown Washington, DC for the latest updates in lung cancer. Dr. Christine Lovly @christine_lovly joins the faculty to discuss biomarkers for NSCLC.

@IASLC endorsed &amp; CME / MOC credits - register today!

medstarhealth.org/dclung25

1.0K

Stephen V Liu, MD@StephenVLiu · Jul 21

FLAURA2 press release: addition of chemotherapy to 1L osimertinib in #EGFR NSCLC improves overall survival. Already approved based on significant PFS benefit. Awaiting data to see degree of OS benefit to consider vs MARIPOSA. Important positive update! astrazeneca.com/media-centre/p…

136

9.0K

Stephen V Liu, MD Retweeted

ALK Positive@ALKPositiveinc · Jul 21

✨ What a weekend!✨ Our 2025 ALK+ Summit wrapped up today — but the connections, knowledge & hope keep going strong. Thank you for showing up & reminding us we’re #StrongerTogether. Stay tuned for more moments from this unforgettable weekend! 💙 #ALKSummit25 #LCSM

7.0K

Stephen V Liu, MD@StephenVLiu · Jul 20

Friends and community at the #ALKSummit2025 - Stronger Together with @DrMarkAwad @christine_lovly @NarjustFlorezMD @JessicaJLinMD @exercise_cancer and Angel Qin @ALKPositiveinc

StephenVLiu's tweet image. Friends and community at the #ALKSummit2025 - Stronger Together with @DrMarkAwad @christine_lovly @NarjustFlorezMD @JessicaJLinMD @exercise_cancer and Angel Qin @ALKPositiveinc

3.0K

Stephen V Liu, MD Retweeted

ALK Positive@ALKPositiveinc · Jul 20

What’s it like being on a #clinicaltrial? When should you join one? Our #ALKSummit25 KOL panel discusses this topic w 2 ALK patients who share their experience joining in 1L & in later settings. Great insights from Dr @StephenVLiu & @christine_lovly #LCSM #StrongerTogether

1.0K

Stephen V Liu, MD Retweeted

IASLC@IASLC · Jul 20

Datopotamab deruxtecan is now FDA approved for EGFR-mutant #NSCLC after prior EGFR & platinum therapy. In this episode of #LungCancerConsidered, @NarjustFlorezMD and @sands_jacob break down the data and clinical implications of this exciting development. 🎧…

2.0K

Stephen V Liu, MD Retweeted

Narjust Florez, MD, FASCO@NarjustFlorezMD · Jul 20

What an amazing day at the 2025 ALK Summit in San Diego @ALKPositiveinc @ALKpositiveINT

3.0K

Stephen V Liu, MD Retweeted

ALK Positive@ALKPositiveinc · Jul 20

At #ALKSummit25 @DanaFarber’s Nancy Campbell says: We hear that “exercise is medicine” & now the CHALLENGE trial confirms it’s true. The good news is not much more required than sneakers & 3-4 brisk 45-60 min walks per week to improve survival. #StrongerTogether #LCSM

1.0K

Stephen V Liu, MD Retweeted

Yvonne Diaz@Yvonne_Diaz_ · Jul 19

Dr @NarjustFlorezMD says the day you get diagnosed w cancer, you become a survivor. At #ALKSummit25, Dr. Florez reminds us around self-care & sexual health is survivorship. If it affects your self-esteem or daily life, talk to your team. You deserve care for all of you. 💙 #LCSM

2.0K

Stephen V Liu, MD@StephenVLiu · Jul 19

Dr. @NarjustFlorezMD on the stage at #ALKSummit2025 discussing survivorship, including self care, communication, stigma, complementary medicine, weight management, and even how to manage a snoring spouse

StephenVLiu's tweet image. Dr. @NarjustFlorezMD on the stage at #ALKSummit2025 discussing survivorship, including self care, communication, stigma, complementary medicine, weight management, and even how to manage a snoring spouse

3.0K

Stephen V Liu, MD Retweeted

Narjust Florez, MD, FASCO@NarjustFlorezMD · Jul 19

We are HERE at the 2025 ALK Summit

2.0K